ClinicalTrials.Veeva

Menu

Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Active, not recruiting

Conditions

Pancreatic Cancer

Treatments

Other: Oral and Fecal Sample Collection

Study type

Observational

Funder types

Other

Identifiers

NCT05689138
PUMCH-PCAMicrobe-1

Details and patient eligibility

About

Pancreatic cancer (PCA) is a leading death-related cancer. There is an urgent need for accurate, noninvasive diagnostic options in the early detection of pancreatic cancer (PCA), since delayed diagnosis increases the risk of metastasis and recurrence. In this study, by analyzing gut and fecal microbial data among the pancreatic versus healthy populations, we aim to establish an early detection tool to improve PCA detection, and to explore potential diagnostic biomarkers.

Enrollment

100 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

PCA Newly diagnosed pancreatic cancer patients; No symptoms of jaundice; Did not yet receive any treatment

NC Individuals who were undergoing routine screenings or physical examination

Exclusion Criteria:

Trial design

100 participants in 2 patient groups

PCA
Description:
pancreatic cancer patients
Treatment:
Other: Oral and Fecal Sample Collection
NC
Description:
normal control
Treatment:
Other: Oral and Fecal Sample Collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems